Analysis

Endo's Attys In 'Career-Wrecking' Peril As Opioid Woes Grow

By Jeff Overley and Cara Salvatore (September 17, 2021, 9:33 PM EDT) -- A flash flood of misconduct inquiries in opioid litigation across the country is rapidly engulfing Endo Pharmaceuticals and threatening to inflict considerable damage on the professional reputations of its Arnold & Porter attorneys, according to legal filings, court proceedings and interviews.

The increasingly intense inquests are focused on failures by Endo and Arnold & Porter to divulge damaging details about the pharmaceutical company's marketing of narcotic painkillers — and whether those discovery deficiencies were inadvertent or intentional.

After the clouds first burst earlier this year with a thunderous default judgment tied to discovery lapses in Tennessee, the drugmaker and the law...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!